Die Entourage Task Force

Entourage Task Force.

We offer. The Task Force. Our pool of experts. Scientists. Engineers. For Pharma. For MedTec. For LabMed. We combine. Strategic expertise. With hands-on implementation. We connect. State of the art concepts. With efficient implementation. Through management consultants. Through Project Consultants. In teams. Interdisciplinary.

Udo Meurle

Udo Meurle studied Business Administration at the Berufsakademie Ravensburg. He also holds a certificate from the Ashridge Advance Management Program and a Strategy Execution certificate.
During his career, which lasted more than 30 years, Mr. Meurle worked for various global companies in the life science industry. He gained international experience in pharmaceuticals, generics, biosimilars, OTCs and medical technology. Mr. Meurle has held senior international positions in Europe, CIS, Asia, South and North America, where his core competencies include Marketing & Sales, Sales Force Effectiveness, Turn around Management and Strategy Execution. He was Managing Director in Germany, Belgium, Czech Republic, Slovakia, Hungary, Romania, Croatia and Italy.
Udo Meurle supports Entourage as a member of the Task Force

Norbert Bleich

Norbert Bleich studied Chemistry at the Albert Ludwig University in Freiburg from where he graduated with a degree.
Mr Bleich looks back on a career of over 20 years in the pharmaceutical industry and has an excellent understanding of development operations, processes, quality and change management, as well as financial controlling. Furthermore, Mr Bleich is also conversant in the local and global development of phramaceutical products. He rounds off his pharmaceutical capabilities with Clinical & Early Clinical Development, Scientific & Regulatory Writing, Global Development Operations & Finance, Biostatistics & Data Management as well as Information & Document Management.

Dr. Michael Stein

Dr Michael Stein studied Pharmacy at the University of Tübingen and earned a PhD in Pharmaceutical Technology at the Free University of Berlin in 1987. He subsequently held a number of positions with various companies in the pharmaceuticals industry, including managerial functions, and built up extensive expertise in the field of the production and release of solids, liquids and parenteral drugs, as well as in quality management, especially auditing and logistics. He is authorised to act as a Qualified Person and is also an expert in GMP compliance and contract manufacturing (both client and contractor).

Arne Briest

After taking a first degree in Biomedical Engineering at the Technical University in Berlin, Arne Briest earned an MBA in Healthcare at the Steinbeis University in Berlin.
In the course of his career, Mr Briest has gained experience in the development and implementation of regulatory strategies in the USA, the EU, Canada, Brazil and China, as well as the implementation of quality management systems in compliance with ISO 13485 and 21CFR820 (QSR). Furthermore, as an interim Regulatory Affairs and Quality Assurance manager Mr Briest is conversant with software-driven dermal fillers, orthopaedic and active implementable devices.

Dr. Peter Riechel

Dr Peter Riechel studied Chemistry, majoring in Technical Chemistry at the University of Hanover and afterwards worked as a research associate in the fields of medical physics and biophysics and technical chemistry at the Universities of Applied Sciences in Münster and Hanover. Dr Riechel has many years of experience in the pharmaceuticals and medical technology industries, with a focus on quality management, quality systems, as well as quality control and analytical development. His core competences lie in the areas of escalation and recall management, CAPA, Six Sigma, project management and root cause investigation in international and interdisciplinary teams. Dr Riechel is also a certified lead auditor for medicinal products in accordance with ISO 13495 and ISO 9001.

Dr. Christoph Tobias Berger

Dr Christoph Tobias Berger studied Pharmacy at Christian Albrecht University in Kiel and graduated from there in 1994 with the qualification of Dr. rer. nat. in Dosage Form Development. The graduate Doctor of Pharmacy also has a management qualification. Dr Berger has many years of experience as a production manager and laboratory manager in the fields of quality assurance and galenics, and as a technical director and Qualified Person pursuant to Section 15 (3a) of the German Medicines Act (AMG). His core competences lie in the fields of tech transfer, supplier auditing and exercising the role of QP for pharmaceutical companies.